{"entity":{"id":"nct05479136","kind":"trial","name":"18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy","aka":[],"tldr":"A phase 3 trial of Fluciclovine F-18 in Glioma & glioblastoma, run by Nicole Hill, with a status the registry has not verified recently.","summary":"18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy is a phase 3 interventional study registered as NCT05479136 by Nicole Hill, with 30 participants planned, started 2022-08-24 and due to reach its primary completion in 2023-12-31. Interventions recorded: PET imaging with 18F fluciclovine. Conditions recorded: Grade III or Grade IV Glioma.\n\nLinked to the drug Fluciclovine F-18 because the registry names it among its interventions and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT05479136","url":"https://clinicaltrials.gov/study/NCT05479136"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["glioblastoma"],"sections":[],"technologies":[],"targets":[],"drugs":["fluciclovine-f18"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05479136","phase":"3","setting":"18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy","sponsor":"Nicole Hill","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05479136/","neighbours":{"cancer":[{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"}],"drug":[{"id":"fluciclovine-f18","kind":"drug","name":"Fluciclovine F-18","route":"/drugs/fluciclovine-f18/"}]}}